Earnings Outlook For Vir Biotechnology
Portfolio Pulse from Benzinga Insights
Vir Biotechnology (NASDAQ:VIR) is scheduled to release its quarterly earnings report on February 22, 2024, with an expected EPS of $-1.08. Analysts and investors will be looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows a mixed impact on its stock price, with the most recent quarter missing EPS estimates by $0.01 but resulting in a 6.96% share price increase the following day. Over the last year, VIR shares have declined by 59.94%.
February 21, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vir Biotechnology is expected to report an EPS of $-1.08 for the upcoming quarter. Past earnings have shown a mixed impact on stock price, with a notable decline of 59.94% over the last year.
The expected EPS and the company's past performance suggest a cautious outlook. While an earnings beat could positively impact the stock, the significant year-to-date decline indicates underlying challenges. The mixed historical reaction to earnings reports adds uncertainty to the short-term price direction.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100